In fact, pro-inflammatory factors that are present at high levels in the blood of patients with type-2 diabetes are IL-1 dependent, and blocking IL-1 activity has been shown to reduce their concentrations [30]. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.